Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pro Natura is a German healthcare company specializing in the development and marketing of enzyme-based solutions for food intolerances. Founded in 1994 and headquartered in Friedrichsdorf, the company became a subsidiary of STADA Arzneimittel in 2013. Its flagship product, Lactrase, is a leading brand for managing lactose intolerance by providing the necessary lactase enzyme for digestion. The company also offers specialized products like Fructosin for fructose malabsorption and Daosin for histamine intolerance, positioning itself as a key player in the European digestive health and nutraceutical market. Pro Natura's products are primarily distributed through pharmacies, providing accessible OTC solutions for patients with metabolic digestive challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pro Natura.